Carisma Therapeutics INC. (CARM) — DEF 14A Filings
All DEF 14A filings from Carisma Therapeutics INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Carisma Seeks Reverse Stock Split Approval to Boost Share Price
— Jul 7, 2025 Risk: high
Carisma Therapeutics Inc. (CARM) is holding a Special Meeting on August 5, 2025, to seek stockholder approval for a reverse stock split. The proposed amendment -
Carisma Therapeutics Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 29, 2024 Risk: low
Carisma Therapeutics Inc. (CARM) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. The 2024 Annual Meeting of Stockholders for Carisma Therapeut
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX